Impact on Health-Related Quality of Life of Parenteral Nutrition for Patients with Advanced Cancer Cachexia: Results from a Randomized Controlled Trial
Open Access
- 25 March 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 25 (5), e843-e851
- https://doi.org/10.1634/theoncologist.2019-0856
Abstract
Background. Malnutrition worsens health-related quality of life (HRQoL) and the prognosis of patients with advanced cancer. This study aimed to assess the clinical benefits of parenteral nutrition (PN) over oral feeding (OF) for patients with advanced cancer cachexia and without intestinal impairment. Material and Methods. In this prospective multicentric randomized controlled study, patients with advanced cancer and malnutrition were randomly assigned to optimized nutritional care with or without supplemental PN. Zelen's method was used for randomization to facilitate inclusions. Nutritional and performance status and HRQoL using the European Organization for Research and Treatment of Cancer QLQ-C15-PAL questionnaire were evaluated at baseline and monthly until death. Primary endpoint was HRQoL deterioration-free survival (DFS) defined as a definitive deterioration of >= 10 points compared with baseline, or death. Results. Among the 148 randomized patients, 48 patients were in the experimental arm with PN, 63 patients were in the control arm with OF only, and 37 patients were not included because of early withdrawal or refused consent. In an intent to treat analysis, there was no difference in HRQoL DFS between the PN arm or OF arm for the three targeted dimensions: global health (hazard ratio [HR], 1.31; 95% confidence interval [CI], 0.88-1.94; p = .18), physical functioning (HR, 1.58; 95% CI, 1.06-2.35; p = .024), and fatigue (HR, 1.19; 95% CI, 0.80-1.77; p = .40); there was a negative trend for overall survival among patients in the PN arm. In as treated analysis, serious adverse events (mainly infectious) were more frequent in the PN arm than in the OF arm (p = .01). Conclusion. PN improved neither HRQoL nor survival and induced more serious adverse events than OF among patients with advanced cancer and malnutrition.Keywords
This publication has 49 references indexed in Scilit:
- Role of nutritional status in predicting quality of life outcomes in cancer – a systematic review of the epidemiological literatureNutrition Journal, 2012
- Oral Nutritional Interventions in Malnourished Patients With Cancer: A Systematic Review and Meta-AnalysisJNCI Journal of the National Cancer Institute, 2012
- Two faces of drug therapy in cancer: drug-related lean tissue loss and its adverse consequences to survival and toxicityCurrent Opinion in Clinical Nutrition and Metabolic Care, 2011
- Definition and classification of cancer cachexia: an international consensusThe Lancet Oncology, 2011
- Prognostic Significance of the “Surprise” Question in Cancer PatientsJournal of Palliative Medicine, 2010
- The development of the EORTC QLQ-C15-PAL: A shortened questionnaire for cancer patients in palliative careEuropean Journal Of Cancer, 2006
- Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: Effects on survival, metabolism, and functionCancer, 2004
- Five-Year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Segmental Mastectomy with or without Radiation in the Treatment of Breast CancerNew England Journal of Medicine, 1985
- ZELEN RANDOMISATIONThe Lancet, 1984
- A New Design for Randomized Clinical TrialsNew England Journal of Medicine, 1979